日本癌治療学会

日本透析医学会

The effect of frailty on the quality of life and lower urinary symptoms following robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL Study).

Kyo Togashi, Shingo Hatakeyama, Yuta Kojima, Masaki Momota, Takuma Narita, Hiromichi Iwamura, Itsuto Hamano, Tomoko Hamaya, Naoki Fujita, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologic oncology   39 ( 3 )   192.e7 - 192.e14   2021年03月

Impact of chronic kidney disease on oncological outcomes in patients with high-risk non-muscle-invasive bladder cancer who underwent adjuvant bacillus Calmette-Guérin therapy.

Naoki Fujita, Shingo Hatakeyama, Kazutaka Okita, Masaki Momota, Takuma Narita, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology   39 ( 3 )   191.e9 - 191.e16   2021年03月

A Longitudinal Study of Bidirectional Relationships between Sleep Disorder and Frequency of Nocturia: Results from the Iwaki Health Promotion Project.

Sakae Konishi, Shingo Hatakeyama, Atsushi Imai, Mika Kumagai, Teppei Okamoto, Kazutaka Okita, Itsuto Hamano, Takuma Narita, Yuta Kojima, Hiromichi Iwamura, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologia internationalis   105 ( 3-4 )   232 - 239   2021年03月

Impact of chronic kidney disease on oncological outcomes in patients with high-risk non-muscle-invasive bladder cancer who underwent adjuvant bacillus Calmette-Guérin therapy.

Fujita N, Hatakeyama S, Okita K, Momota M, Narita T, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

Urologic oncology   39 ( 3 )   191.e9 - 191.e16   2021年03月

The effect of frailty on the quality of life and lower urinary symptoms following robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL Study).

Togashi K, Hatakeyama S, Kojima Y, Momota M, Narita T, Iwamura H, Hamano I, Hamaya T, Fujita N, Okamoto T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Urologic oncology   39 ( 3 )   192.e7 - 192.e14   2021年03月

Relationship of frailty with treatment modality selection in patients with muscle-invasive bladder cancer (FRART-BC study).

Iwamura H, Hatakeyama S, Momota M, Kojima Y, Narita T, Okamoto T, Fujita N, Hamano I, Togashi K, Hamaya T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Translational andrology and urology   10 ( 3 )   1143 - 1151   2021年03月

Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study).

Tomoko Hamaya, Shingo Hatakeyama, Masaki Momota, Takuma Narita, Hiromichi Iwamura, Yuta Kojima, Itsuto Hamano, Naoki Fujita, Teppei Okamoto, Kyo Togashi, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International journal of clinical oncology   26 ( 1 )   199 - 206   2021年01月

Therapeutic effects of the combined androgen blockade therapy versus luteinizing hormone-releasing hormone analog monotherapy in patients with hormone naïve metastatic prostate cancer: a multi-institutional comparative analysis.

Takuma Narita, Shingo Hatakeyama, Shintaro Narita, Masahiro Takahashi, Toshihiko Sakurai, Sadafumi Kawamura, Senji Hoshi, Jiro Shimoda, Toshiaki Kawaguchi, Shigeto Ishidoya, Koji Mitsuzuka, Yoichi Arai, Akihiro Ito, Norihiko Tsuchiya, Tomonori Habuchi, Chikara Ohyama

Translational andrology and urology   10 ( 1 )   417 - 425   2021年01月

Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study).

Hamaya T, Hatakeyama S, Momota M, Narita T, Iwamura H, Kojima Y, Hamano I, Fujita N, Okamoto T, Togashi K, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

International journal of clinical oncology   26 ( 1 )   199 - 206   2021年01月

Therapeutic effects of the combined androgen blockade therapy versus luteinizing hormone-releasing hormone analog monotherapy in patients with hormone naïve metastatic prostate cancer: a multi-institutional comparative analysis.

Narita T, Hatakeyama S, Narita S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Shimoda J, Kawaguchi T, Ishidoya S, Mitsuzuka K, Arai Y, Ito A, Tsuchiya N, Habuchi T, Ohyama C

Translational andrology and urology   10 ( 1 )   417 - 425   2021年01月

RARCと回腸を利用した尿路変向術

米山 高弘, 畠山 真吾, 橋本 安弘, 大山 力, 富樫 赳, 堀口 裕貴, 小玉 寛健, 成田 拓磨, 岩村 大径, 小島 由太, 岡本 哲平, 山本 勇人

Japanese Journal of Endourology   34 ( 1 )   24 - 32   2021年

A Longitudinal Study of Bidirectional Relationships between Sleep Disorder and Frequency of Nocturia: Results from the Iwaki Health Promotion Project.

Konishi S, Hatakeyama S, Imai A, Kumagai M, Okamoto T, Okita K, Hamano I, Narita T, Kojima Y, Iwamura H, Yamamoto H, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C

Urologia internationalis   105 ( 3-4 )   232 - 239   2021年

Oncologic and patient-reported outcomes after robot-assisted radical prostatectomy in men aged ≥75 years.

Togashi K, Hatakeyama S, Okamoto T, Kojima Y, Iwamura H, Fujita N, Narita T, Hamano I, Hamaya T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Urologic oncology   2020年12月

Impact of the Proportion of Biopsy Positive Core in Predicting Biochemical Recurrence in Patients with Pathological Pt2 and Negative Resection Margin Status after Radical Prostatectomy.

Oikawa M, Tanaka T, Narita T, Noro D, Iwamura H, Tobisawa Y, Yoneyama T, Kodama H, Hashimoto Y, Koie T, Ohyama C

Pathology oncology research : POR   26 ( 4 )   2115 - 2121   2020年10月

Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer.

Fujita N, Hatakeyama S, Momota M, Kido K, Narita T, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

Urologic oncology   38 ( 8 )   684.e17 - 684.e24   2020年08月

Castration-resistant prostate cancer without metastasis at presentation may achieve cancer-specific survival in patients who underwent prior radical prostatectomy.

Kodama H, Koie T, Oikawa M, Narita T, Tanaka T, Noro D, Iwamura H, Tobisawa Y, Yoneyama T, Hashimoto Y, Ohyama C

International urology and nephrology   52 ( 4 )   671 - 679   2020年04月

ハイリスク前立腺癌に対する術前内分泌化学療法後のロボット支援前立腺全摘術 (RARP) の治療成績

米山 高弘, 今井 篤, 畠山 真吾, 橋本 安弘, 大山 力, 濱谷 智子, 百田 匡毅, 濱野 逸人, 成田 拓磨, 岩村 大径, 小島 由太, 岡本 哲平, 山本 勇人

Japanese Journal of Endourology   33 ( 2 )   325 - 329   2020年

Clinical Characterization of Low Prostate-specific Antigen on Prognosis in Patients With Metastatic Castration-naive Prostate Cancer.

Kodama H, Hatakeyama S, Narita S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Narita T, Sato H, Mitsuzuka K, Tochigi T, Tsuchiya N, Arai Y, Habuchi T, Ohyama C

Clinical genitourinary cancer   17 ( 6 )   e1091 - e1098   2019年12月

Evaluating the effects of switching from dutasteride to tadalafil in benign prostatic hyperplasia patients with lower urinary tract symptoms: A randomized, open-label, multicenter study.

Matsumoto T, Hatakeyama S, Narita T, Yoneyama T, Hashimoto Y, Ohyama C

International journal of urology : official journal of the Japanese Urological Association   26 ( 4 )   522 - 523   2019年04月

Neoadjuvant chemohormonal therapy followed by robot-assisted and minimum incision endoscopic radical prostatectomy in patients with high-risk prostate cancer: comparison of perioperative and oncological outcomes at single institution.

Fujita N, Koie T, Hashimoto Y, Narita T, Tobisawa Y, Tanaka T, Noro D, Oikawa M, Hagiwara K, Yoneyama T, Imai A, Yamamoto H, Hatakeyama S, Yoneyama T, Ohyama C

International urology and nephrology   50 ( 11 )   1999 - 2005   2018年11月

Significance of Serum N-glycan Profiling as a Diagnostic Biomarker in Urothelial Carcinoma.

Oikawa M, Hatakeyama S, Yoneyma T, Tobisawa Y, Narita T, Yamamoto H, Hashimoto Y, Koie T, Narita S, Sasaki A, Tsuchiya N, Habuchi T, Takahashi I, Nakaji S, Ohyama C

European urology focus   4 ( 3 )   405 - 411   2018年04月

Cost-effectiveness comparison between neoadjuvant chemohormonal therapy and extended pelvic lymph node dissection in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.

Matsumoto T, Hatakeyama S, Ookubo T, Mitsuzuka K, Narita S, Inoue T, Yamashita S, Narita T, Koie T, Kawamura S, Tochigi T, Tsuchiya N, Habuchi T, Arai Y, Ohyama C

Medical oncology (Northwood, London, England)   34 ( 12 )   190   2017年10月

Preoperative chronic kidney disease predicts poor oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.

Kodama H, Hatakeyama S, Fujita N, Iwamura H, Anan G, Fukushi K, Narita T, Tanaka T, Kubota Y, Horiguchi H, Momota M, Kido K, Matsumoto T, Soma O, Hamano I, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Sasaki A, Kawaguchi T, Sato M, Ohyama C

Oncotarget   8 ( 47 )   83183 - 83194   2017年10月

Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer.

Hamano I, Hatakeyama S, Iwamurau H, Fujita N, Fukushi K, Narita T, Hagiwara K, Kusaka A, Hosogoe S, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Kawaguchi T, Ohyama C

Oncotarget   8 ( 37 )   61404 - 61414   2017年09月

Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer.

Kusaka A, Hatakeyama S, Hosogoe S, Hamano I, Iwamura H, Fujita N, Fukushi K, Narita T, Hagiwara K, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Kawaguchi T, Ohyama C

Oncotarget   8 ( 39 )   65492 - 65505   2017年09月

Presence of transient hydronephrosis immediately after surgery has a limited influence on renal function 1 year after ileal neobladder construction.

Narita T, Hatakeyama S, Koie T, Hosogoe S, Matsumoto T, Soma O, Yamamoto H, Yoneyama T, Tobisawa Y, Yoneyama T, Hashimoto Y, Ohyama C

BMC urology   17 ( 1 )   72   2017年08月

Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer.

Kusaka A, Hatakeyama S, Hosogoe S, Hamano I, Iwamura H, Fujita N, Fukushi K, Narita T, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Kawaguchi T, Ohyama C

Medical oncology (Northwood, London, England)   34 ( 5 )   90   2017年05月

Difference in toxicity reporting between patients and clinicians during systemic chemotherapy in patients with urothelial carcinoma.

Fukushi K, Narita T, Hatakeyama S, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ohyama C

International journal of urology : official journal of the Japanese Urological Association   24 ( 5 )   361 - 366   2017年05月

Clinical relevance of aortic calcification in urolithiasis patients.

Tanaka T, Hatakeyama S, Yamamoto H, Narita T, Hamano I, Matsumoto T, Soma O, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Takahashi I, Nakaji S, Terayama Y, Funyu T, Ohyama C

BMC urology   17 ( 1 )   25   2017年04月

Clinical implications of serum N-glycan profiling as a diagnostic and prognostic biomarker in germ-cell tumors.

Narita T, Hatakeyama S, Yoneyama T, Narita S, Yamashita S, Mitsuzuka K, Sakurai T, Kawamura S, Tochigi T, Takahashi I, Nakaji S, Tobisawa Y, Yamamoto H, Koie T, Tsuchiya N, Habuchi T, Arai Y, Ohyama C

Cancer medicine   6 ( 4 )   739 - 748   2017年04月

Quality-of-life evaluation during platinum-based neoadjuvant chemotherapies for urothelial carcinoma.

Fukushi K, Narita T, Hatakeyama S, Yamamoto H, Soma O, Matsumoto T, Tobisawa Y, Yoneyama T, Imai A, Yoneyama T, Hashimoto Y, Koie T, Ohyama C

International journal of clinical oncology   22 ( 2 )   366 - 372   2017年04月

Clinical implications of serum N-glycan profiling as a diagnostic and prognostic biomarker in germ-cell tumors.

Takuma Narita, Shingo Hatakeyama, Tohru Yoneyama, Shintaro Narita, Shinichi Yamashita, Koji Mitsuzuka, Toshihiko Sakurai, Sadafumi Kawamura, Tatsuo Tochigi, Ippei Takahashi, Shigeyuki Nakaji, Yuki Tobisawa, Hayato Yamamoto, Takuya Koie, Norihiko Tsuchiya, Tomonori Habuchi, Yoichi Arai, Chikara Ohyama

Cancer medicine   2017年03月

Difference in toxicity reporting between patients and clinicians during systemic chemotherapy in patients with urothelial carcinoma.

Ken Fukushi, Takuma Narita, Shingo Hatakeyama, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   2017年03月

Quality-of-life evaluation during platinum-based neoadjuvant chemotherapies for urothelial carcinoma.

Ken Fukushi, Takuma Narita, Shingo Hatakeyama, Hayato Yamamoto, Osamu Soma, Teppei Matsumoto, Yuki Tobisawa, Tohru Yoneyama, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

International journal of clinical oncology   22 ( 2 )   366 - 372   2017年03月

Aortic calcification burden predicts deterioration of renal function after radical nephrectomy.

Ken Fukushi, Shingo Hatakeyama, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Osamu Soma, Teppei Matsumoto, Itsuto Hamano, Takuma Narita, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Yuriko Terayama, Tomihisa Funyu, Chikara Ohyama

BMC urology   17 ( 1 )   13 - 13   2017年02月

Aortic calcification burden predicts deterioration of renal function after radical nephrectomy.

Fukushi K, Hatakeyama S, Yamamoto H, Tobisawa Y, Yoneyama T, Soma O, Matsumoto T, Hamano I, Narita T, Imai A, Yoneyama T, Hashimoto Y, Koie T, Terayama Y, Funyu T, Ohyama C

BMC urology   17 ( 1 )   13   2017年02月

The impact of extended lymph node dissection versus neoadjuvant therapy with limited lymph node dissection on biochemical recurrence in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.

Takuma Narita, Takuya Koie, Teppei Ookubo, Koji Mitsuzuka, Shintaro Narita, Hayato Yamamoto, Takamitsu Inoue, Shingo Hatakeyama, Sadafumi Kawamura, Tatsuo Tochigi, Tomonori Habuchi, Yoichi Arai, Chikara Ohyama

Medical oncology (Northwood, London, England)   34 ( 1 )   1 - 1   2017年01月

The impact of extended lymph node dissection versus neoadjuvant therapy with limited lymph node dissection on biochemical recurrence in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.

Narita T, Koie T, Ookubo T, Mitsuzuka K, Narita S, Yamamoto H, Inoue T, Hatakeyama S, Kawamura S, Tochigi T, Habuchi T, Arai Y, Ohyama C

Medical oncology (Northwood, London, England)   34 ( 1 )   1   2017年01月

The influence of serum uric acid on renal function in patients with calcium or uric acid stone: A population-based analysis.

Tanaka Y, Hatakeyama S, Tanaka T, Yamamoto H, Narita T, Hamano I, Matsumoto T, Soma O, Okamoto T, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Takahashi I, Nakaji S, Terayama Y, Funyu T, Ohyama C

PloS one   12 ( 7 )   e0182136   2017年

Correction: Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer.

Shingo Hatakeyama, Takuya Koie, Takuma Narita, Shogo Hosogoe, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

PloS one   11 ( 3 )   e0151742 - e0151742   2016年

Correction: Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer.

Hatakeyama S, Koie T, Narita T, Hosogoe S, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C

PloS one   11 ( 3 )   e0151742   2016年

Renal Function Outcomes and Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer [corrected].

Hatakeyama S, Koie T, Narita T, Hosogoe S, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C

PloS one   11 ( 2 )   e0149544   2016年

The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential.

Fujita H, Morii T, Fujishima H, Sato T, Shimizu T, Hosoba M, Tsukiyama K, Narita T, Takahashi T, Drucker DJ, Seino Y, Yamada Y

Kidney international   85 ( 3 )   579 - 89   2014年03月

[Capillary hemangioma in renal hilum; a case report].

Oikawa M, Hatakeyama S, Hamano I, Tanaka T, Tanaka Y, Narita T, Noro D, Hagiwara K, Ohyama C

Hinyokika kiyo. Acta urologica Japonica   60 ( 1 )   33 - 7   2014年01月

Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center.

Hatakeyama S, Yoneyama T, Hamano I, Murasawa H, Narita T, Oikawa M, Hagiwara K, Noro D, Tanaka T, Tanaka Y, Hashimoto Y, Koie T, Ohyama C

BMC urology   13   47   2013年10月

Switching hemodialysis patients from sevelamer hydrochloride to bixalomer: a single-center, non-randomized analysis of efficacy and effects on gastrointestinal symptoms and metabolic acidosis.

Hatakeyama S, Murasawa H, Narita T, Oikawa M, Fujita N, Iwamura H, Mikami J, Kojima Y, Sato T, Fukushi K, Ishibashi Y, Hashimoto Y, Koie T, Saitoh H, Funyu T, Ohyama C

BMC nephrology   14   222   2013年10月

Prognosis of elderly Japanese patients aged ≥80 years undergoing hemodialysis.

Hatakeyama S, Murasawa H, Hamano I, Kusaka A, Narita T, Oikawa M, Noro D, Hagiwara K, Ishimura H, Yoneyama T, Hashimoto Y, Koie T, Saitoh H, Funyu T, Ohyama C

TheScientificWorldJournal   2013   693514   2013年